Treatment decision-making in the 1L mNSCLC setting:
learnings from patient cases

Wednesday 24 May, 2023
20:00 - 21:30 h

Given the growing number of treatment options available for metastatic non-small cell lung cancer (mNSCLC), it is not always evident which option is best for a particular patient - if a ‘best option’ even exists. This is especially true for physicians who have no or only limited experience with all available options. This live webinar will focus on experiences with various 1L (dual) immunotherapies within metastatic NSCLC.

Based on patient cases, the experts will discuss to what extend different patient characteristics (e.g. ECOG, age, brain/liver metastases, molecular profile) but also local healthcare environment (e.g. organization within hospital, MDT and network collaboration) should be taken into account when concluding to a treatment rationale for a particular patient. Ultimate question is: what is the impact from any particular treatment?
During the webinar you will have the opportunity to ask your burning questions to the panel.